62373-05-1

Upstream product

• 84210-55-9 ethyl [(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]acetate 
• 6232-82-2 5-methyl-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione 

Downstream Products

• 1428354-44-2 4-phenyl-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-45-3 4-(4-bromophenyl)-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-46-4 4-(4-chlorophenyl)-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-47-5 4-(4-methoxyphenyl)-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-48-6 4-benzyl-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-49-7 4-(4-methoxybenzyl)-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-50-0 4-cyclohexyl-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-51-1 4-ethyl-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-52-2 4-allyl-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 200815-83-4 [(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]acetic acid 
• 1428354-31-7 4-carboxymethyl-5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-32-8 5-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-2,5-dihydro-4H-1,2,4-triazole-3(2H)-thione 
• 1428354-53-3 (5-aminophenyl)-2-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-1,3,4-thiadiazole 
• 1428354-54-4 [5-amino-(4-chlorophenyl)]-2-{[(4-phenyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-1,3,4-thiadiazole 

Relevant academic research and scientific papers

Synthesis and in vitro antimicrobial activity of new 4-phenyl-5-methyl-4H-1,2,4-triazole-3-thione derivatives

This study presents the synthesis, spectral analysis and antimicrobial evaluation of a new series of substituted 1,2,4-triazole (5a-i) and 1,3,4-thiadiazole derivatives (9a, c, g, h). New compounds were obtained by cyclization reaction of acyl thiosemicarbazide derivatives in the presence of alkaline and acidic media. All synthesized compounds were screened for their in vitro antimicrobial activities. Nine of the compounds had potential activity against Gram-positive bacteria (MIC = 3.91-500 μg/mL). Some compounds showed good activity especially against: Micrococcus luteus ATCC 10240 (MIC = 3.91-31.25 μg/mL), Bacillus subtilis ATCC 6633 (MIC = 15.63-62.5 μg/mL), and Staphylococcus aureus ATCC 25923 (MIC = 15.63-125 μg/mL).

Synthesis and Antimicrobial Evaluation of New Schiff Base Hydrazones Bearing 1,2,4-Triazole Moiety

This study presents the synthesis and spectral analysis of new Schiff base hydrazone derivatives. New compounds were prepared by the reaction of [(4-phenyl-5-substituted-4H-1,2,4-triazol-3-yl)sulfanyl] acetohydrazide with various aldehydes. The structures

Synthesis and in vitro antimicrobial activity of new 4-phenyl-5-methyl-4H- 1,2,4-triazole-3-thione derivatives

This study presents the synthesis, spectral analysis and antimicrobial evaluation of a new series of substituted 1,2,4-triazole (5a-i) and 1,3,4-thiadiazole derivatives (9a, c, g, h). New compounds were obtained by cyclization reaction of acyl thiosemicarbazide derivatives in the presence of alkaline and acidic media. All synthesized compounds were screened for their in vitro antimicrobial activities. Nine of the compounds had potential activity against Gram-positive bacteria (MIC=3.91-500 g/mL). Some compounds showed good activity especially against: Micrococcus luteus ATCC 10240 (MIC=3.91-31.25 g/mL), Bacillus subtilis ATCC 6633 (MIC=15.63- 62.5 /mL), and Staphylococcus aureus ATCC 25923 (MIC=15.63-125 g/mL).